Signal Transduction and Human Disease (PDF)

Acknowledgments. Contributors. Introduction. 1. Atherosclerosis: Signal Transduction by Oxygen and Nitrogen Radicals (Jonathan M. Hill, Ilsa I. Rovira, and Toren Finkel). 2. NF-kB:A Key Signaling Pathway in Asthma (Stewart J. Levine). 3. Molecular Mechanisms of Cancer (Akrit Sodhi, Silvia Montaner, and J. Silvio Gutkind). 4. Apoptotic Pathways in Cancer Progression and Treatment (Joya Chandra and Scott H. Kaufmann). 5. Molecular and Cellular Aspects of Insulin Resistance: Implications for Diabetes (Derek Le Roith, Michael J. Quon, and Yehiel Zick). 6. Dysfunction of G Protein-Regulated Pathways and Endocrine Diseases (William F. Simonds). 7. Bacterial Regulation of the Cytoskeleton (Jeremy W. Peck, Dora C. Stylianou, and Peter D. Burbelo). 8. Bacterial Toxins and Diarrhea (Walter A. Patton, Joel Moss, and Martha Vaughan). 9. Molecular Basis of Severe Combined Immunodeficiency: Lessons from Cytokine Signaling Pathways (Roberta Visconti, Fabio Candotti, and John J. O'Shea). 10. Mast Cell-Related Diseases: Genetics, Signaling Pathways, and Novel Therapies (Michael A. Beaven and Thomas R. Hundley). 11. Rheumatology and Signal Transduction (Keith M. Hull and Daniel L. Kastner). 12. Molecular Mechanisms of Neurodegenerative Disorders (Benjamin Wolozin). 13. Neurotrophic Signaling in Mood Disorders (Jing Du,Todd D. Gould, and Husseini K. Manji). 14. Inhibiting Signaling Pathways Through Rational Drug Design (James N.Topper and Neill A. Giese). Index.

Dr. Toren Finkel is Chief of the Cardiovascular Branch,
National Heart Lung and Blood Institute, National Institutes of
Health (NIH, DHHS). He received his undergraduate training in
physics and then completed a combined M.D./Ph.D. program at Harvard
Medical School. Following graduation he pursued an internal medical
residency at the Massachusetts General Hospital in Boston and a
Cardiology Fellowship at Johns Hopkins School of Medicine in
Baltimore. His laboratory has been interested in the role of
oxidants as signaling molecules and the participation of free
radicals in human disease.

Dr. J. Silvio Gutkind is Chief of the Oral and Pharyngeal
Cancer Branch, National Institute of Dental and Craniofacial
Research, National Institutes of Health (NIH, DHHS). He received
his Ph.D. in pharmacy and biochemistry from the University of
Buenos Aires, Argentina. His laboratory has addressed the molecular
basis of cancer by studying normal and aberrant functions of
molecules involved in the transduction of proliferative signals. He
also leads a multi-institutional effort aimed to elucidate the
molecular changes that contribute to the evolution of squamous cell
carcinomas.

Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.